Co-Authors
This is a "connection" page, showing publications co-authored by Guogang Xu and Runsheng Wang.
Connection Strength
1.662
-
Regional Differences in Epidemiological and Clinical Characteristics, Treatment, and Clinical Outcomes of COVID-19 in Wuhan and Remote Areas of Hubei Province. Front Med (Lausanne). 2021; 8:667623.
Score: 0.239
-
A Tip of the Iceberg on the Mechanism of SARS-CoV-2-Induced Liver Injury. Am J Gastroenterol. 2021 05 01; 116(5):1097-1098.
Score: 0.236
-
Cytokine release syndrome in COVID-19: a major mechanism of morbidity and mortality. Int Rev Immunol. 2022; 41(2):217-230.
Score: 0.233
-
Clinical characteristics of re-hospitalized COVID-19 patients with recurrent positive SARS-CoV-2 RNA: a retrospective study. Eur J Clin Microbiol Infect Dis. 2021 Jun; 40(6):1245-1252.
Score: 0.231
-
Clinical Pathway for Early Diagnosis of COVID-19: Updates from Experience to Evidence-Based Practice. Clin Rev Allergy Immunol. 2020 Aug; 59(1):89-100.
Score: 0.224
-
Clinical Features of 85 Fatal Cases of COVID-19 from Wuhan. A Retrospective Observational Study. Am J Respir Crit Care Med. 2020 06 01; 201(11):1372-1379.
Score: 0.221
-
Psychological responses among nurses caring for patients with COVID-19: a comparative study in China. Transl Psychiatry. 2021 05 06; 11(1):273.
Score: 0.059
-
Corrigendum to "The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China" [J. Autoimmun. 109C (2020) 102434]. J Autoimmun. 2020 07; 111:102487.
Score: 0.055
-
Clinical Characteristics of COVID-19 Patients With Digestive Symptoms in Hubei, China: A Descriptive, Cross-Sectional, Multicenter Study. Am J Gastroenterol. 2020 05; 115(5):766-773.
Score: 0.055
-
Management and Treatment of COVID-19: The Chinese Experience. Can J Cardiol. 2020 06; 36(6):915-930.
Score: 0.055
-
The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China. J Autoimmun. 2020 05; 109:102434.
Score: 0.054